Independent simulation estimates ~19% probability of null Lp(a) biology and reduces OCEAN(a)'s modeled statistical-success probability from 87.9% to ~65–72%
Cytonics, a biotechnology research and development company specialising in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences Platform, to manage its electronic Trial Master File...
